Aigen Investment Management’s Agios Pharmaceuticals AGIO Stock Holding History

Aigen Investment Management’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-25,915	Closed	-$705K	–	509
2025 Q4	$705K	Buy	+25,915	New	+$909K	0.16%	189
2023 Q1	–	Sell	-9,814	Closed	-$276K	–	598
2022 Q4	$276K	Buy	+9,814	New	+$277K	0.04%	380
2020 Q4	–	Sell	-23,112	Closed	-$809K	–	758
2020 Q3	$809K	Buy	+23,112	New	+$1.01M	0.1%	307
2020 Q2	–	Sell	-22,114	Closed	-$785K	–	788
2020 Q1	$785K	Buy	22,114 +13,636	+161%	+$630K	0.1%	282
2019 Q4	$405K	Buy	+8,478	New	+$320K	0.07%	377

Other funds holding AGIO

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return

D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return

BNP Paribas Asset Management

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return